U.S. Consumer Finance Stock News

In late April 2026, Corcept Therapeutics reported a first-quarter net loss of US$31.76 million versus net income of US$20.55 million a year earlier, while also raising its 2026 revenue guidance to US$950 million–US$1.05 billion on the back of strong prescription trends and the early FDA approval of Lifyorli for platinum-resistant ovarian cancer. At the same time, promising long-term survival data from the Phase 2 DAZALS trial in ALS and an advancing cortisol-modulation pipeline highlight how...

To understand whether Ford Motor stock offers good value at today’s price, you first need to know how that price compares with key measures like cash flows, earnings and assets, not just the headline share chart. Over the last week the stock recorded a 0.6% decline, while the 30 day return stands at 4.8%. The year to date return is an 8.8% decline and the 1 year return is 24.5%, with 3 and 5 year returns of 22.1% and 43.1% respectively. Recent coverage around Ford Motor has focused on broader...

In early May 2026, Patterson-UTI Energy completed a US$499.27 million offering of 6.050% senior unsecured notes due 2036 and extended US$450 million of its revolving credit facility to 2031, reinforcing balance sheet flexibility following a quarter in which earnings and revenue exceeded expectations. Alongside these financing moves, a series of routine insider stock sales and equity awards occurred while an affiliate of Blackstone reduced its ownership below 5%, highlighting an ongoing...

TeraWulf (WULF) has drawn fresh attention after closing a US$1.0b stock offering to fund a large AI focused data center project in Kentucky, alongside a well publicized shift away from purely bitcoin mining. See our latest analysis for TeraWulf. The recent US$1.0b stock offering and pivot toward AI focused infrastructure have coincided with very strong momentum. The 30 day share price return is 65.53% and the year to date share price return is 102.04%, on top of a very large 1 year total...

In early May 2026, Cabaletta Bio reported early RESET-PV trial data showing biologic and clinical activity for its rese-cel CAR T therapy in refractory pemphigus vulgaris patients treated at the lowest dose without chemotherapy preconditioning, alongside a completed US$150.00 million follow-on equity offering priced at US$2.90 per share. An interesting angle for investors is Cabaletta’s 10-year commercial supply agreement with Cellares, which aims to support automated, higher-throughput...

If you are wondering whether Ensign Group's current share price lines up with its underlying worth, you are not alone in asking if the stock still offers value after its recent run. The stock closed at US$175.93, with returns of 28.7% over 1 year and 117.5% over 5 years, although the past month shows an 11.1% pullback and a 5.6% decline over 7 days, leaving year to date returns at 1.2%. Recent attention on Ensign Group has centered on how the market is reassessing healthcare operators and...

Investors may be wondering whether General Mills is starting to look like value at its current share price, or if the stock still does not stack up on valuation grounds. The stock last closed at US$35.07, with returns of 1.7% over 7 days, a 6.9% decline over 30 days, and longer term returns of a 23.3% decline year to date and a 31.9% decline over 1 year. These moves have come as investors continue to reassess packaged food companies and their sensitivity to changing consumer habits and cost...

Earlier this week, Sterling Infrastructure reported record first-quarter 2026 results, with revenue rising to US$825.68 million and net income reaching US$95.97 million, and it raised full-year guidance to US$3.70–US$3.80 billion in revenue, US$513–US$533 million in net income, and diluted EPS of US$16.50–US$17.15. Management also highlighted an active hunt for acquisitions, particularly in E-Infrastructure and electrical services, aiming to broaden Sterling’s service offering and geographic...

Dine Brands Global (DIN) opened Q1 2026 with revenue of US$225.2 million and basic EPS of US$0.59, while trailing 12 month figures showed revenue of US$889.7 million and EPS of US$1.13, setting up a quarter where headline growth sits against relatively thin profitability. Over recent periods, the company has seen revenue move from US$214.8 million in Q1 2025 to US$225.2 million in Q1 2026, with basic EPS shifting alongside from US$0.53 to US$0.59 as trailing net income settled at US$15.4...

Texas Pacific Land (NYSE:TPL) reported record revenue and net income for the first quarter. The company agreed to a major land sale and water supply deal tied to a large scale data center project with a power plant developer. Texas Pacific Land appointed Peter Doyle, a leader at its largest shareholder, to the Board and its acquisitions committee. Texas Pacific Land, trading around $419.75, has had a mixed return profile, with a 40.9% gain year to date and a 181.8% return over 3 years,...

If you are wondering whether Innovative Industrial Properties stock still offers value at its recent price of US$57.70, this breakdown will help you judge how the current market price stacks up against underlying fundamentals. The stock has posted returns of 8.4% over the last 7 days, 16.7% over 30 days, 16.6% year to date and 25.1% over 1 year, alongside a 10.1% return over 3 years and a 47.0% decline over 5 years. Recent pricing shifts sit against a backdrop of continuing investor...

Wondering if C.H. Robinson Worldwide at around US$168.59 still offers value after a strong run? This article breaks down what the current price might be implying. The stock has returned 96.2% over the past year, with a small 0.2% 30 day decline and a 9.6% pullback over the last week. This may have caught your eye if you are tracking potential entry or exit points. Recent attention on C.H. Robinson Worldwide has focused on its share price performance and how the market is reassessing...

Luxfer Holdings PLC's ( NYSE:LXFR ) stock was strong despite it releasing a soft earnings report last week. Our...

Tutor Perini Corporation has now reported its first-quarter 2026 results, with sales rising to US$1,389.46 million from US$1,246.63 million a year earlier, while net income eased to US$25.7 million and diluted earnings per share from continuing operations softened to US$0.48. The combination of higher revenue but slightly lower profitability highlights how the company’s expanding project activity is not yet fully translating into higher per-share earnings. We’ll now examine how this strong...

Enpro Inc. has already reported first-quarter 2026 results, with sales rising to US$303.0 million from US$273.2 million and net income increasing to US$27.4 million from US$24.5 million, alongside an updated full-year outlook calling for 10%–14% revenue growth. Management’s decision to raise guidance, maintain a quarterly dividend of US$0.3200 per share, and highlight semiconductor-driven demand and acquisitions underlines how Enpro is leaning on higher-value growth areas while still...

If you are wondering whether Trimble's current share price reflects its true worth, it helps to step back and separate short term share price noise from longer term valuation signals. Trimble closed at US$63.42, with returns of 4.3% over the last week, 2.5% over the last month, 19.0% year to date, 4.3% over the last year, 33.1% over three years, and 14.1% over five years. This gives you a mix of shorter and longer term results to weigh up. Recent news coverage has focused on Trimble's...

If you have been wondering whether Otis Worldwide stock is attractively priced or just fairly valued at around US$76.71, the key is to look closely at what the current valuation actually reflects. Over the last week the stock is roughly flat with a 0.1% return, while the 30 day return of a 1.8% decline and the 1 year return of a 19.7% decline hint that sentiment around the long term story has shifted. Recent coverage has focused on how elevator and escalator demand ties into broader...

CBL & Associates Properties (CBL) has completed refinancing for Fayette Mall in Lexington, Kentucky, replacing a $98.6 million loan with a $97.5 million five-year non-recourse CMBS facility at an approximate 7.25% fixed rate. See our latest analysis for CBL & Associates Properties. The refinancing news lands after a strong run in the stock, with a 30 day share price return of 7.63%, a 90 day gain of 21.73% and a 1 year total shareholder return of 92.43%, suggesting momentum has been building...

Wave Life Sciences Ltd. recently reported first-quarter 2026 results, with sales rising to US$38.25 million from US$9.18 million a year earlier and net loss narrowing to US$26.09 million. This combination of stronger revenue and a smaller loss per share suggests the company’s operations may be scaling more efficiently than in the prior-year period. With revenue more than quadrupling year over year, we’ll now examine how this improved financial performance influences Wave Life Sciences’...

If you are wondering whether DoorDash at around US$167.97 still represents good value or growing risk, the answer depends on which valuation lens you use and how you think its story plays out from here. The stock has seen mixed returns, with a 0.8% decline over the last week, an 8.3% gain over the last month, a 23.6% decline year to date, and a 5.1% decline over the last year, while still sitting on a very large 3 year return of 144.3% and a 5 year return of 48.7%. Recent coverage has...

ZJK Industrial Co., Ltd. ( NASDAQ:ZJK ) announced strong profits, but the stock was stagnant. Our analysis suggests...

Wondering if ON Semiconductor at around US$105.77 is still offering value, or if the easy money has already been made. The stock has returned 7.0% over the last week, 66.6% over the last month, 86.5% year to date and 172.6% over the past year, with longer term 3 year and 5 year returns of 32.4% and 196.5%. Recent price action has kept ON Semiconductor in focus as investors weigh how current expectations line up with the company’s positioning in the semiconductor sector. Broader interest in...

Understanding Nu Holdings after recent share performance Nu Holdings (NYSE:NU) has drawn fresh attention after recent share performance that includes a month gain of 1.5% alongside a negative move of 13.9% over the past 3 months, prompting investors to reassess the stock. See our latest analysis for Nu Holdings. At a share price of $14.48, Nu Holdings has seen short term share price momentum fade, with a 7 day share price return of 3.13% set against a 3 month share price decline of 13.86%,...

In early May 2026, Incyte received U.S. FDA approval for Jakafi XR, a once-daily extended-release ruxolitinib tablet for multiple hematologic and graft-versus-host disease indications, after bioequivalence and safety were established against the existing twice-daily formulation. This approval, alongside materially higher first-quarter 2026 revenue of US$1.27 billion and net income of US$303.33 million versus a year earlier, underscores how incremental product enhancements and portfolio...